Genex Infosys PLC announcements
128 Dhaka Stock Exchange announcements for Genex Infosys PLC (GENEXIL) since 2021: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (37).
- Alpha Credit Rating Limited (AlphaRating) has assigned surveillance rating of the Company as \"A+\" in the long term and
Alpha Credit Rating Limited (AlphaRating) has assigned surveillance rating of the Company as \"A+\" in the long term and \"ST-2\" in the short term along with a stable outlook based on audited financial statements of the Company as on June 30, 2022 and relevant qualitative information till December 10, 2022.
- Update of Information
The Company has requested the concerned Merchant Banks and all Depository Participants (DPs) to provide copies of the list of margin clients along with the bank details for entitlement of dividends on or before December 29, 2022 as per the following: i) Hard copy: Through registered mail or courier to Share Department of the Company ii) Soft copy: Email to [email protected]
- Declaration of share transfer by a Director
Chowdhury Fazle Imam, one of the Directors of the company, has expressed his intention to transfer 18,00,000 shares out of his holdings 1,35,14,417 shares of the company to his brother Chowdhury Fazle Alam (General Shareholder of the company), by way of gift outside the trading system of the Exchange within next 30 working days from the date of issuance of approval letter by DSE.
- Resumption after record date
Trading of the shares of the Company will resume on 21.11.2022 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 20.11.2022
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 16.11.2022 to 17.11.2022. Trading of the shares of the Company will remain suspended on record date i.e., 20.11.2022.
- The Company has informed that the Board of Directors has approved an Agreement with National Board of Revenue (NBR) to b
The Company has informed that the Board of Directors has approved an Agreement with National Board of Revenue (NBR) to be called \"Agreement for Distribution, Installation and Maintenance of Electronic Fiscal Device (EFD) and Sales Data Controller (SDC) Machines and monitoring the operation of the installed machines to ensure the collection of Value Added Tax (VAT) and Supplementary Duty (SD) from different type (Cont.1)
- (Continuation news of GENEXIL): of business entities through Electronic Fiscal Device Management System (EFDMS) for Zone
(Continuation news of GENEXIL): of business entities through Electronic Fiscal Device Management System (EFDMS) for Zone1: Jurisdiction Area of Customs Excise and VAT Commissionerate, Dhaka (North) and Customs Excise and VAT Commissionerate, Dhaka (West), for Zone 2: Jurisdiction Area of Customs Excise and VAT Commissionerate, Dhaka (South) and Customs Excise and VAT Commissionerate, Dhaka (East) and for Zone 3: Jurisdiction Area of (Cont.2)
The first part of this announcement is missing from the archive. - (Continuation news of GENEXIL): Customs Excise and VAT Commissionerate, Chattogram\". Under this agreement, Genex Infosy
(Continuation news of GENEXIL): Customs Excise and VAT Commissionerate, Chattogram\". Under this agreement, Genex Infosys Limited will distribute Electronic Fiscal Device (EFD) and Sales Data Controller (SDC) among eligible retailers and wholesalers and monitor the operation of the installed machines to ensure the collection of Value Added Tax (VAT) and Supplementary Duty (SD). Along with that, Genex Infosys Ltd. (Cont.3)
The first part of this announcement is missing from the archive. - (Continuation news of GENEXIL): will also develop a software solution, termed VAT API System for interfacing with EFD/SD
(Continuation news of GENEXIL): will also develop a software solution, termed VAT API System for interfacing with EFD/SDC machines and integrating with ERP/POS solutions existing in the market. The tenure of this Agreement is 10 years. Genex Infosys Ltd. will supply and install a total of 3,00,000 (Three Lakh) EFD/SDC machines in three different zones (Cont.4)
The first part of this announcement is missing from the archive. - Board approval of an Agreement with National Board of Revenue
(Continuation news of GENEXIL): within the next 5 years. This agreement is expected to generate approximate gross revenue of Tk. 212.00 crore per year upon full rollout within the next 5 years. (end)
The first part of this announcement is missing from the archive. - (Continuation news of GENEXIL): The Company has reported Consolidated EPS of Tk. 3.36, Consolidated NAV per share of Tk.
(Continuation news of GENEXIL): The Company has reported Consolidated EPS of Tk. 3.36, Consolidated NAV per share of Tk. 16.53 and Consolidated NOCFPS of Tk. 5.08 for the year ended June 30, 2022 as against Tk. 2.93, Tk. 18.22 and Tk. 4.82 respectively for the same period of the previous year. Reasons for declaration of Bonus Share: a) Bonus Shares have been recommended in view to utilize its retained amount as capital for further business expansion. (cont. 2)
The first part of this announcement is missing from the archive. - The Board of Directors has recommended 11\% Cash Dividend excluding Sponsors and Directors and 2\% Stock Dividend for al
The Board of Directors has recommended 11\% Cash Dividend excluding Sponsors and Directors and 2\% Stock Dividend for all shareholders for the year ended June 30, 2022. Total Shares: 113,546,400, Sponsors\' and Directors\' Shares: 35,966,240, General Shareholders\' Shares: 77,580,160. Cash of Tk. 85,338,176.00 will be paid to general shareholders. Date of AGM: 29.12.2022, Time: 3:00 PM, Venue: Digital Platform. Record Date: 20.11.2022. (cont. 1)
- Dividend Declaration
(Continuation news of GENEXIL): b) Bonus shares are declared out of accumulated profit. c) Bonus shares are not declared from capital reserve or revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the company or through reducing paid up capital or through doing anything so that the post dividend retained earnings become negative or a debit balance. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (30.10.2022) following its corporate declaration. However, as per the BSEC Order No. BSEC/CMRRCD/2001-07/39 dated July 28, 2022, the floor price shall be applicable accordingly.
- Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 1.39 for July-September 2022 as against Tk. 1.29 for July-September 2021; Consolidated NOCFPS was Tk. 1.74 for July-September 2022 as against Tk. 1.75 for July-September 2021. Consolidated NAV per share was Tk. 18.10 as on September 30, 2022 and Tk. 19.64 as on September 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2022 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2022 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.
- In response to a DSE query dated October 02, 2022 regarding clarification on recent news published in the newspaper, the
In response to a DSE query dated October 02, 2022 regarding clarification on recent news published in the newspaper, the Company has informed that Published news on October 02, 2022 titled \"To collect Value Added Tax (VAT) by GENEXIL\", the Company has informed that as per their ongoing business development and expansion activities, they are continuously working relentlessly to ensure new business for the company. As such, participating in many Private and Public Tenders (cont. 1)
- (Continuation news of GENEXIL): is a regular activity for the Company. In one such case, the Company participated in a T
(Continuation news of GENEXIL): is a regular activity for the Company. In one such case, the Company participated in a Tender for Distribution, Installation and Maintenance of Electronic Fiscal Device (EFD) and Sales Data Controller (SDC) Machines and monitoring the operation of the installed machine to ensure the collection of Value Added Tax (VAT) and Supplementary Duty (SD) from different types of business entities through Electronic Fiscal Device Management System (EFDMS). (cont. 2)
The first part of this announcement is missing from the archive. - (Continuation news of GENEXIL): On September 14, 2022 they found the same news item that the Honorable Cabinet Committee
(Continuation news of GENEXIL): On September 14, 2022 they found the same news item that the Honorable Cabinet Committee on Government purchase (CCGP) approved the budget and reported that they have selected for the work. They have had several meetings to answer queries of the Honorable Procurement Entity and are jointly working towards the completion of the required documentation. However, as the above article refers to an internal (cont. 3)
The first part of this announcement is missing from the archive. - Response to DSE's Query
(Continuation news of GENEXIL): and confidential process of the Honorable Government of Bangladesh and as a matter of the Ministry of Finance and the National Board of Revenue, it would be inappropriate to comment till the completion of the appropriate formalities. On Completion, they will immediately take all necessary and regulatory steps to maintain full compliance, for further perusal. (end)
The first part of this announcement is missing from the archive. - Board approval of an Agreement with Standard Chartered Bank, Bangladesh
The Company has informed that Board of Directors has approved an Agreement with Standard Chartered Bank, Bangladesh. Under this agreement, the company will work as a strategic partner, assisting the Bank with engaging a wider client-base & scaling up its distribution network, efficiently reaching new client segments and thereby delivering world-class banking products and services to a broader customer group. From this project, the company is expected to generate approximately BDT 6 crore revenue per year.
- The Company has informed that the Board of Directors has decided to sign an agreement with \"Banglalink Digital Communic
The Company has informed that the Board of Directors has decided to sign an agreement with \"Banglalink Digital Communications Ltd.\". Under this agreement Genex will be managing the Customer Experience Operations for the Telecom Operator for next 5 years. The Agreement covers services the Company has been providing since 2017, and the entire scope has been enhanced and renewed for a further 5 years. From this project the company is expected to generate BDT 12.00 crore revenue per year.
- Confirmation of share transfer by a Director
Mr. Prince Mojumder one of the Directors of the company, has further informed that he has completed his transfer of 6,00,000 shares of the company to his mother Mrs. Momota Rani Ray (General Shareholder of the company), by way of gift outside the trading system of the Exchange as per declaration disseminated on 28.04.2022.
- Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 0.69 for January-March 2022 as against Tk. 1.06 for January-March 2021; Consolidated EPS was Tk. 3.26 for July 2021-March 2022 as against Tk. 2.79 for July 2020-March 2021. Consolidated NOCFPS was Tk. 3.50 for July 2021-March 2022 as against Tk. 3.12 for July 2020-March 2021. Consolidated NAV per share was Tk. 18.54 as on March 31, 2022 and Tk. 18.22 as on June 30, 2021.
- Declaration of share transfer
Mr. Prince Mojumder one of the Directors of the company, has expressed his intention to transfer 6,00,000 shares out of his holding 46,42,969 shares of the company to his mother Mrs. Momota Rani Ray (General Shareholder of the company), by way of gift outside the trading system of the Exchange within April 28, 2022 from the date of issuance of approval letter by DSE.
- GENNEXT: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2022 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.
- Board Meeting schedule under LR 16(1)
(Correction): As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2022 at 2:15 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.
- Dividend Disbursement
The Company has informed that it has credited the Bonus shares for the year ended June 30, 2021 to the respective shareholders' BO Accounts.
- Resumption after record date
Trading of the shares of the company will resume on 20.02.2022 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 17.02.2022.
- Spot News for entitlement of Stock Dividend
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 15.02.2022 to 16.02.2022. Trading of the shares of the Company will remain suspended on record date i.e., 17.02.2022.
- Consent from BSEC and Record date for entitlement of 10% Stock Dividend
The Company has further informed that BSEC has accorded consent for issuance of 10% Stock Dividend for the year ended June 30, 2021. The Company has also informed that the Board of Directors has fixed the Record date on 17.02.2022 for entitlement of the aforesaid Bonus Shares.
- Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 1.33 for October-December 2021 as against Tk. 0.98 for October-December 2020. Consolidated EPS was Tk. 2.74 for July-December 2021 as against Tk. 1.90 for July-December 2020. Consolidated NOCFPS was Tk. 3.62 for July-December 2021 as against Tk. 2.25 for July-December 2020. Consolidated NAV per share was Tk. 19.96 as on December 31, 2021 and Tk. 18.22 as on December 31, 2020.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2022 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2021.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2021 to the respective shareholders.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.